Results 131 to 140 of about 28,279 (174)
Some of the next articles are maybe not open access.
Infection Control, 1986
In recent years there have been great advances made in antiviral therapy. One of the most promising of the new agents to be introduced is acyclovir. This antiviral, which selectively inhibits the replication of particular DNA viruses, is being used clinically in the treatment and prevention of viral infections caused by several of the herpes viruses ...
C A, Zabrosky, G, Milkovich
openaire +2 more sources
In recent years there have been great advances made in antiviral therapy. One of the most promising of the new agents to be introduced is acyclovir. This antiviral, which selectively inhibits the replication of particular DNA viruses, is being used clinically in the treatment and prevention of viral infections caused by several of the herpes viruses ...
C A, Zabrosky, G, Milkovich
openaire +2 more sources
New England Journal of Medicine, 1992
REPORTS of the clinical efficacy of acyclovir, a selective and specific inhibitor of herpesvirus replication, appeared in the literature a decade ago.
Alastair J.J. Wood +2 more
openaire +2 more sources
REPORTS of the clinical efficacy of acyclovir, a selective and specific inhibitor of herpesvirus replication, appeared in the literature a decade ago.
Alastair J.J. Wood +2 more
openaire +2 more sources
Journal of Antimicrobial Chemotherapy, 1983
Acyclovir given intravenously in either low dose (5 mg/kg every 8 h) or high dose (500 mg/m2 every 8 h) significantly reduced pain and accelerated skin healing in acute herpes zoster occurring in otherwise healthy adults. The higher dose also significantly reduced the duration of viral shedding. No significant effect on post-herpetic neuralgia could be
B, Bean, D, Aeppli, H H, Balfour
openaire +2 more sources
Acyclovir given intravenously in either low dose (5 mg/kg every 8 h) or high dose (500 mg/m2 every 8 h) significantly reduced pain and accelerated skin healing in acute herpes zoster occurring in otherwise healthy adults. The higher dose also significantly reduced the duration of viral shedding. No significant effect on post-herpetic neuralgia could be
B, Bean, D, Aeppli, H H, Balfour
openaire +2 more sources
Scandinavian Journal of Infectious Diseases, 1988
Acyclovir crystals in the urine of a 28-year-old woman are described. The patient received intravenous acyclovir for herpes encephalitis. The crystalluria was accompanied by impairment of the renal tubules as evidenced by increased urinary beta-2-microglobulin excretion. Consecutive series of 60 patients on oral acyclovir and 20 patients on intravenous
N A, Peterslund, M L, Larsen, H, Mygind
openaire +2 more sources
Acyclovir crystals in the urine of a 28-year-old woman are described. The patient received intravenous acyclovir for herpes encephalitis. The crystalluria was accompanied by impairment of the renal tubules as evidenced by increased urinary beta-2-microglobulin excretion. Consecutive series of 60 patients on oral acyclovir and 20 patients on intravenous
N A, Peterslund, M L, Larsen, H, Mygind
openaire +2 more sources
2000
Abstract The chemistry developed for the synthesis of the antiviral acyclic nucleotide acyclovir is an interesting example of competition among industrial research groups as this product is a generic drug. There are more than 20 bulk producers worldwide1 and, among them, Quimica Synthetica SA, Lachema AS, Recordati SpA, Heumann Pharma ...
Walter Cabri, Romano Di Fabio
openaire +2 more sources
Abstract The chemistry developed for the synthesis of the antiviral acyclic nucleotide acyclovir is an interesting example of competition among industrial research groups as this product is a generic drug. There are more than 20 bulk producers worldwide1 and, among them, Quimica Synthetica SA, Lachema AS, Recordati SpA, Heumann Pharma ...
Walter Cabri, Romano Di Fabio
openaire +2 more sources